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Introduction
The use of cytostatics drugs in anticancer therapy is increasing. Health care workers can be occupationally exposed
to these drugs classified as carcinogenic, mutagenic or teratogenic (IARC, 1987, 1997). Cytostatics drugs are an
heterogeneous group of chemicals widely used in the treatment of cancer, nevertheless have been proved to be also
mutagens, carcinogens and teratogens. Workers may be exposed to this drug, being in the hospital settings the main
focus dwelled upon the pharmacy, and nursing personnel. Alkaline comet assay is one of the most promising short-
term genotoxicity assays for human risk assessment, being recommended to monitor populations chronically
exposed to genotoxic agents. DNA glycosylase (OGG1) represents the main mechanism of protecting the integrity of
the human DNA with respect to 8-OHdG, the most well studied biomarker of oxidative damage.
Research Aim and Methods
This study intended to assess genotoxic effects of cytostatics occupational exposure by alkaline comet assay.
The study population consisted of 46 exposed subjects working as pharmacists, pharmacy technicians, and nurses that 
handle cytostatics drugs and 46 unexposed control subjects. The alkaline comet assay was used to evaluate the 
genotoxicity towards peripheral blood lymphocytes, and the slides were stained with DAPI. Percentage of DNA in the 
tail and oxidative damage parameters were measured with Perceptive Instruments® software. The genotype of the 
polymorphisms OGG1 (rs1052133) was studied by Real Time PCR using the iCycler iQ® Multicolor Real-Time PCR. 
Conclusions
Occupational exposure to cytostatics drugs is associated with genotoxic effects. In this study, the results of the comet 
assay analyzed parameters were higher in exposed in comparison with controls, however not significant. Also the 
study of the susceptibility biomarkers did not show statistical significant differences.
Results
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Table 1 - Descriptive statistics of % DNA in tail and FPG means by gender and 
exposure (mean mean standard error, range). 
Groups Gender N % DNA in tail 
Mean ± S.E. 
(range)
FPG
Mean ± S.E.
(range)
Exposed
Females 40 14.84±1.38
(1.79-31.64)
5.31±0.61
(0.19-13.91)
Males 6 17.43±5.96
(4.61-44.50)
5.39±1.09
(2.38-9.65)
Controls
Females 34 14.15±1.49
(2.48-30.43)
4.57±0.74
(0.02-14.46)
Males 12 7.46±1.54
(2.79-18.49)
4.65±0.89
(0.10-9.61)
 No statistical significant differences were found
in both parameters between the exposed and
control groups, and the three possible OGG1
genotypes.
Groups OGG1 N % DNA Tail
Mean S.E.
(range)
FPG
Mean S.E.
(range)
Exposed
Cys/Cys 7 13.11 2.80
(1.79 – 23.53) 
5.03 1.48
(0.27 – 12.0) 
Ser/Cys 14 13.23 1.42
(2.48 – 28.19) 
4.97 0.72
(0.10 – 14.46) 
Ser/Ser 25 14.26 1.38
(2.68 – 44.50) 
4.94 0.51
(0.02 – 12.90) 
p-value 0.777 0.647
Controls
Cys/Cys 2 14.22 9.31
(4.91 – 23.53)
7.39 4.61
(2.78 – 12.00)
Ser/Cys 18 12.04 1.86
(2.48 – 28.19)
4.69 1.00
(0.10 – 14.46)
Ser/Ser 26 12.52 1.74
(2.68 – 30.43)
4.30 0.73
(0.02 – 12.69)
p-value 0.906 0.682
Table 2 - Descriptive statistics of % DNA Tail and FPG means in the studied population 
(mean mean standard error, median, and range) by OGG1 Ser326Cys 
polymorphisms and exposure, p-value of Kruskal-Wallis test.
 Project supported by Autoridade para as Condições de Trabalho
(Projeto 036APJ/09)
 Acknowledgement to AP Tox for AP Tox grant
 Corresponding author: carina.ladeira@estesl.ipl.pt
